Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor

被引:5
|
作者
Liu, Zhong-wei [1 ]
Li, Wen-qiang [2 ]
Wang, Jun-kui [1 ]
Ma, Xian-cang [3 ]
Liang, Chen [4 ]
Liu, Peng [5 ]
Chu, Zheng [5 ]
Dang, Yong-hui [5 ,6 ,7 ]
机构
[1] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 3, Xian 710068, Peoples R China
[2] Northwestern Polytech Univ, Sch Astronaut, Xian 710072, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Psychiat, Affiliated Hosp 1, Xian 710061, Peoples R China
[4] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Peoples R China
[5] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710061, Peoples R China
[6] Xi An Jiao Tong Univ, Hlth Sci Ctr, Hlth Minist Forens Med, Key Lab, Xian 710061, Peoples R China
[7] Xi An Jiao Tong Univ, Hlth Sci Ctr, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Peoples R China
来源
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B | 2014年 / 15卷 / 12期
基金
中国国家自然科学基金;
关键词
Zirconium oxide; Ceramic foam; Glial cell line-derived neurotrophic factor (GDNF); Parkinson's disease; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; FACTOR GDNF; RAT MODEL; GROWTH-FACTORS; NEURONS; EXPRESSION; INFUSION; BDNF; TRANSPLANTATION;
D O I
10.1631/jzus.B1400163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study investigated the potential application of a zirconium oxide (ZrO2) ceramic foam culturing system to the production of glial cell line-derived neurotrophic factor (GDNF). Three sets of ZrO2 ceramic foams with different pore densities of 10, 20, and 30 pores per linear inch (PPI) were prepared to support a 3D culturing system. After primary astrocytes were cultured in these systems, production yields of GDNF were evaluated. The biomaterial biocompatibility, cell proliferation and activation of cellular signaling pathways in GDNF synthesis and secretion in the culturing systems were also assessed and compared with a conventional culturing system. In this study, we found that the ZrO2 ceramic foam culturing system was biocompatible, using which the GDNF yields were elevated and sustained by stimulated cell proliferation and activation of signaling pathways in astrocytes cultured in the system. In conclusion, the ZrO2 ceramic foam is promising for the development of a GDNF mass production device for Parkinson's disease treatment.
引用
收藏
页码:1013 / 1022
页数:10
相关论文
共 50 条
  • [1] Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor氧化锆陶瓷泡沫: 一种有望大规模生产GDNF 的生物支持材料
    Zhong-wei Liu
    Wen-qiang Li
    Jun-kui Wang
    Xian-cang Ma
    Chen Liang
    Peng Liu
    Zheng Chu
    Yong-hui Dang
    Journal of Zhejiang University SCIENCE B, 2014, 15 : 1013 - 1022
  • [2] Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor
    Garbayo, E.
    Ansorena, E.
    Lanciego, J. L.
    Aymerich, M. S.
    Blanco-Prieto, M. J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 344 (1-2) : 9 - 15
  • [3] Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential
    Y. A. Sidorova
    M. Saarma
    Molecular Biology, 2016, 50 : 521 - 531
  • [4] Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential
    Sidorova, Y. A.
    Saarma, M.
    MOLECULAR BIOLOGY, 2016, 50 (04) : 521 - 531
  • [5] Unraveling the role of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
    Kakoty, Violina
    Sarathlal, K. C.
    Kaur, Palwinder
    Wadhwa, Pankaj
    Vishwas, Sukriti
    Khan, Farhan R.
    Alhazmi, Abdulfattah Yahya M.
    Almasoudi, Hassan Hussain
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Paudel, Keshav Raj
    Kumar, Dileep
    Dua, Kamal
    Singh, Sachin Kumar
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1409 - 1418
  • [6] Role of Glial Cell Line-Derived Neurotrophic Factor in the Maintenance of Adult Mesencephalic Catecholaminergic Neurons
    Enterria-Morales, Daniel
    Lopez-Lopez, Ivette
    Lopez-Barneo, Jose
    d'Anglemont de Tassigny, Xavier
    MOVEMENT DISORDERS, 2020, 35 (04) : 565 - 576
  • [7] Progress in research of glial cell line-derived neurotrophic factor.
    Chen, Y
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1996, 23 (06) : 524 - 526
  • [8] Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease
    Whone, Alan L.
    Boca, Mihaela
    Luz, Matthias
    Woolley, Max
    Mooney, Lucy
    Dharia, Sonali
    Broadfoot, Jack
    Cronin, David
    Schroers, Christian
    Barua, Neil U.
    Longpre, Lara
    Barclay, C. Lynn
    Boiko, Chris
    Johnson, Greg A.
    Fibiger, H. Christian
    Harrison, Rob
    Lewis, Owen
    Pritchard, Gemma
    Howell, Mike
    Irving, Charlie
    Johnson, David
    Kinch, Suk
    Marshall, Christopher
    Lawrence, Andrew D.
    Blinder, Stephan
    Sossi, Vesna
    Stoessl, A. Jon
    Skinner, Paul
    Mohr, Erich
    Gill, Steven S.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (02) : 301 - 313
  • [9] Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons
    Enterria-Morales, Daniel
    Lopez-Gonzalez del Rey, Natalia
    Blesa, Javier
    Lopez-Lopez, Ivette
    Gallet, Sarah
    Prevot, Vincent
    Lopez-Barneo, Jose
    d'Anglemont de Tassigny, Xavier
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [10] GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR GENE THERAPY AMELIORATES CHRONIC HYPERPROLACTINEMIA IN SENILE RATS
    Morel, G. R.
    Sosa, Y. E.
    Bellini, M. J.
    Carri, N. G.
    Rodriguez, S. S.
    Bohn, M. C.
    Goya, R. G.
    NEUROSCIENCE, 2010, 167 (03) : 946 - 953